Clear ×
Curanex Pharmaceuticals Inc CURX

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Oct 19, 2026 8-K 2 signals fired
Other
Form S3 Shelf Registration Disclosure Litigation Defense Assertion
Sep 4, 2026 8-K 2 signals fired
Other
Reverse Stock Split Effected Nasdaq Minimum Bid Price Delisting Notice
Aug 17, 2026 8-K 5 signals fired
Other
Reverse Stock Split Effected Nyse Listing Disclosure Nasdaq Minimum Bid Price Delisting Notice Fractional Share Cash Payment Equity Plan Board Approval Conditional On Shareholder Vote
Aug 14, 2026 10-Q 20 signals fired · top 15
Other
Warrant Valued Black Scholes Net Loss Reported Capital Raising Uncertainty Disclosed Restrictive Debt Covenants Disclosure Reverse Stock Split Effected Other Income Expense Disclosure Nasdaq Minimum Bid Price Delisting Notice Nyse Listing Disclosure Form S3 Shelf Registration Disclosure Equity Compensation Accounting Policy Ipo Or Capital Raising Completion Equity Award Plan Types Enumerated Shares Outstanding Disclosure Incorporation Or Reincorporation Disclosure
Core
Indication Expansion
May 14, 2026 10-Q 13 signals fired
Other
Net Loss Reported Ipo Net Proceeds Disclosure Ipo Or Capital Raising Completion Other Income Expense Disclosure Nyse Listing Disclosure Incorporation Or Reincorporation Disclosure Shares Outstanding Disclosure Institutional Investment Operating Lease Rent Expense Disclosed Nasdaq Minimum Bid Price Delisting Notice
Core
Indication Expansion Lead Asset Progress
Biotech v3
Ai Drug Discovery Investment
May 14, 2026 8-K 10 signals fired
Core
Clinical Trial Result Indication Expansion Lead Asset Progress Clinical Hold Secondary Endpoint Mentioned Combination Therapy Mentioned
Other
Interim Data Positive Patient Retention High Fda Aligned
Biotech v3
Ind Submission Planned
May 7, 2026 8-K 1 signal fired
Other
Nasdaq Minimum Bid Price Delisting Notice